Viewing Study NCT04830267


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-01-18 @ 4:03 PM
Study NCT ID: NCT04830267
Status: RECRUITING
Last Update Posted: 2024-03-28
First Post: 2021-03-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy of Camrelizumab Plus Stereotactic Body Radiotherapy in R/M NPC
Sponsor: Chongqing University Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module